<DOC>
	<DOCNO>NCT02640443</DOCNO>
	<brief_summary>The investigator evaluate whether sulfamethoxazole , sulfamide antibiotic , improve symptom primary PREPL deficiency ( hypotonia-cystinuria syndrome isolate PREPL deficiency ) .</brief_summary>
	<brief_title>Sulfamethoxazole Treatment Primary PREPL Deficiency</brief_title>
	<detailed_description />
	<mesh_term>Cystinuria</mesh_term>
	<mesh_term>Chromosome Deletion</mesh_term>
	<mesh_term>Intellectual Disability</mesh_term>
	<mesh_term>Muscle Hypotonia</mesh_term>
	<mesh_term>Craniofacial Abnormalities</mesh_term>
	<mesh_term>Mitochondrial Diseases</mesh_term>
	<mesh_term>Sulfamethoxazole</mesh_term>
	<criteria>patient molecular confirmation primary PREPL deficiency able follow study protocol ( primary endpoint ) give write informed consent age &lt; 2m woman childbearing age unless use reliable method contraception pregnant study entrance additional diagnosis influence muscle force able follow study protocol ( primary endpoint ) history sulfonamide hypersensitivity diminish renal function base serum creatinine transaminases high 3 time upper limit normal pupillometry : eye pathology exception refractive error , drug influence pupillary light reflex</criteria>
	<gender>All</gender>
	<minimum_age>2 Months</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>